BR0211562A - Derivados de indol tetracìclicos como agentes de ligação receptores de 5-ht - Google Patents
Derivados de indol tetracìclicos como agentes de ligação receptores de 5-htInfo
- Publication number
- BR0211562A BR0211562A BR0211562-0A BR0211562A BR0211562A BR 0211562 A BR0211562 A BR 0211562A BR 0211562 A BR0211562 A BR 0211562A BR 0211562 A BR0211562 A BR 0211562A
- Authority
- BR
- Brazil
- Prior art keywords
- binding agents
- compounds
- receptor binding
- indole derivatives
- tetracyclic indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"DERIVADOS DE INDOL TETRACìCLICOS COMO AGENTES DE LIGAçãO RECEPTORES DE 5-HT". A presente invenção proporciona compostos de fórmula (I), onde n R~ 1~, R~ 2~, R~ 3~, R~ 4~, Y, b e c, apresentam qualquer um dos valores definidos na especificação, assim como as composições farmacêuticas que compreendem os compostos. A presente invenção proporciona também métodos terapêuticos para tratamento de doenças onde a modulação de atividade 5-HT é desejada, assim como processos e intermediários úteis para a preparação dos compostos de fórmula I.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31033201P | 2001-08-06 | 2001-08-06 | |
PCT/US2002/025073 WO2003028733A1 (en) | 2001-08-06 | 2002-08-05 | Tetracyclic indole derivatives as 5-ht receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211562A true BR0211562A (pt) | 2004-07-13 |
Family
ID=23202032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211562-0A BR0211562A (pt) | 2001-08-06 | 2002-08-05 | Derivados de indol tetracìclicos como agentes de ligação receptores de 5-ht |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030060462A1 (pt) |
EP (1) | EP1423123A1 (pt) |
JP (1) | JP2005504114A (pt) |
BR (1) | BR0211562A (pt) |
CA (1) | CA2453343A1 (pt) |
MX (1) | MXPA04001201A (pt) |
WO (1) | WO2003028733A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6994384B2 (en) * | 2002-11-20 | 2006-02-07 | General Electric Company | Integrated solitary bumper beam |
EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
EP2516396A1 (en) * | 2009-12-23 | 2012-10-31 | Wayne State University | Therapeutic compounds |
EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5314900A (en) * | 1992-11-19 | 1994-05-24 | Merck Frosst Canada, Inc. | Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis |
PE20010052A1 (es) * | 1999-04-23 | 2001-01-27 | Upjohn Co | Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht |
ES2228549T3 (es) * | 1999-06-15 | 2005-04-16 | Bristol-Myers Squibb Pharma Company | Gamma-carbolinas condensadas con heterociclo sustituido. |
WO2002004456A1 (en) * | 2000-07-06 | 2002-01-17 | Pharmacia & Upjohn Company | SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES |
-
2002
- 2002-08-03 US US10/212,664 patent/US20030060462A1/en not_active Abandoned
- 2002-08-05 EP EP02800309A patent/EP1423123A1/en not_active Withdrawn
- 2002-08-05 WO PCT/US2002/025073 patent/WO2003028733A1/en not_active Application Discontinuation
- 2002-08-05 MX MXPA04001201A patent/MXPA04001201A/es unknown
- 2002-08-05 BR BR0211562-0A patent/BR0211562A/pt not_active IP Right Cessation
- 2002-08-05 CA CA002453343A patent/CA2453343A1/en not_active Abandoned
- 2002-08-05 JP JP2003532065A patent/JP2005504114A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1423123A1 (en) | 2004-06-02 |
WO2003028733A1 (en) | 2003-04-10 |
MXPA04001201A (es) | 2004-05-20 |
US20030060462A1 (en) | 2003-03-27 |
JP2005504114A (ja) | 2005-02-10 |
CA2453343A1 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001090068A3 (en) | Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases | |
BR0211559A (pt) | Compostos, composições de ligantes tetracìclicos terapeuticamente úteis e seus usos | |
BRPI0509761B8 (pt) | compostos de quinolinona-carboxamida como agonistas de receptor de 5-ht4, composição farmacêutica, uso dos referidos compostos e seu processo de preparação | |
BR0215151A (pt) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
BR0206633A (pt) | Derivados de 1-aril- ou 1-arilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6 | |
BR0312758A (pt) | Derivados de 1-heterociclilalquil-3-sulfonilazaindol ou -azaindazol como ligantes da 5-hidroxitriptamina-6 | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
BRPI0407976A (pt) | tetrahidroisoquinolinas substituìdas em 2,5 e 2,6 para uso como moduladores de 5-ht6 | |
WO2007081299A3 (en) | Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators | |
WO2006004931A3 (en) | Substituted azepine derivatives as serotonin receptor modulators | |
BR0209056A (pt) | Derivados de heterociclilóxi-, -tióxi- e -aminobenzazol como ligantes de 5-hidroxitriptamina-6 | |
BR0307631A (pt) | Piridinonas substituìdas como moduladores de p38 map-quinase | |
WO2005113494A3 (en) | Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer | |
BR0312759A (pt) | Derivados de 1-heterociclilalquil-3-sulfonilindol ou -indazol como ligantes de 5-hidroxitriptamina-6 | |
BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
BR0213094A (pt) | Derivados de cromano como ligandos de 5-hidroxi-triptamina-6 | |
BR0213417A (pt) | Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos | |
BR0309664A (pt) | Derivados de [1,4]diazepino[6,7,1-ij]quinolina como agentes anti-psicóticos e antiobesidade | |
WO2006028961A3 (en) | Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
WO2001017963A3 (en) | Aminoalkoxy carbazoles and their use as 5-ht ligands | |
BR0215222A (pt) | Derivados de indolilalquilamina como ligantes de 5-hidroxitriptamina-6 | |
EA200001085A1 (ru) | 5-аминоиндено [1, 2-с]пиразол-4-оны в качестве противораковых и антипролиферативных агентов | |
BR0213464A (pt) | Derivados de 3-azabiciclo[3.1.0]hexano como antagonistas receptores de opióide | |
BRPI0413565A (pt) | análogos de quinazolina como inibidores de receptor de tirosina quinase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A., 6A., E 7A. ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |